Acquisition, In-Licensing Arrangement, Sale of Investment, Research and Development Arrangement and Collaborative Arrangement - Research and Development Arrangement (Details) - Abingworth [Member] - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended |
|---|---|---|---|
Jun. 28, 2026 |
Sep. 27, 2026 |
Sep. 27, 2026 |
|
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||
| Research and development arrangement, maximum funding amount | $ 300 | ||
| Research and development arrangement, funding to offset costs incurred | $ 19 | $ 45 | |
| Clinical Trial Agreement Terms [Member] | |||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||
| Maximum potential cash payments | $ 180 | $ 180 | |
| Payment period (in years) | 18 months | 18 months | |
| Net Sales and Royalty Agreement Terms [Member] | |||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||
| Maximum potential cash payments | $ 420 | $ 420 | |
| Payment period (in years) | 3 years | 3 years |